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The liver occupies a central place in protein metabolism. Most serum pro­
teins are synthesized in hepatocytes. The elements of reticulo-histiocyte system 
and other hepatic structures participate actively in catabolism of serum proteins 
already realized their biological role. Protein synthesis, intracellular transport 
and excretion are disturbed in chronic liver diseases (3). Assessment of individual 
serum proteins (ISP) concentration provides valuable data about the functional 
state of the liver. Increased immunoglobulin level is a characteristic feature of 
dysproteinemia in many cases with liver diseases (17). Their enhanced synthesis 
in these diseases is a sign of an immune reaction. Recently, the significance of 
the investigation of serum immunoglobulins (Ig) as indices of humoral immune 
mechanisms concerning diagnosis and prognosis both rises in relation with the 
ascertaining of immune mechanises in chronic alcoholic hepatic lesions (1 , 4, 
16, 19). With a view to clinical interpretation of dysproteinemia in liver diseases 
discussion of characteristic disturbances of ISP levels in various nosological 
units is warranted, indeed. Numerous authors (6—9, 11 —14) show convincingly 
the importance of ISP assessment for the differential diagnosis of liver diseases, 
for evaluation of the course of the pathological processes and prognosis as well. 
Material and methods 
A total of 360 patients with liver diseases were studied complexly clinico-
laboratorily and morphologically in the profile Gastroenterological Clinic of 
the Higher Institute of Medicine, Varna during a 8-year period. Their mean age 
was 53 years. We excluded by means of all methods available other organic di­
seases which could cause abnormalities of individual serum protein levels and of 
immune processes in the organism. The following patients' groups were formed: 
patients with an acute viral hepatitis (AVH), chronic active hepatitis (САН), 
chronic persistent hepatitis (CPH), liver steatosis (LS) , liver cirrhosis (LC) , he­
patic carcinoma (HC), and extrahepatic cholestasis (EC) . ISP were determined 
by using of specific reactions (8) but Igs by means of monospecific antisera with 
radial immunodiffusion according to Mancini, Carbonara and Heremans. Data 
were compared with these of control healthy individuals within reference values 
adopted in the literature. Patients were profoundly clinically discussed and a 
statistical analysis (variance, correlation, percentile and alternative one) was 
performed. 
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Results and discussion 
Our results showed that most sensitive reactions were observed when sialic 
acid (SA), cholinesterase (CE) , hexosamines (HA) and fucose (F) from the class of 
glycoproteins were concerned. Their changes were distinctly expressed in almost 
all the groups excepting of C P H and L S patients only (see table 1). 
I SA was increased in patients with САН, L C , L S , E C , and HC being most 
elevated in the latter two groups (fig. 1). 
T a b l e 1 
Serum glycoproteins In pxtieits with Itver diseases and in control persons 
Mean glycoprotein ievel 
Patients' 
group SA mg% Hp mg% Or mg% Cp Ul C E mU/ml HA mg% F mg% 
(mmol) (g/1) (g/1) (mkmol) (kE) (mmol) (mmol) 
Controls 60 66.75 99.66 4.57 55.8 2960 71 8.43 
(24.03) (0.996) (0.0457) (3.48) (2.960) (3.9689) (0.5134) 
V H 94 73.87 93.18 3.54 67.02 2444 93.25 13.03 
(26.59) (0.931) (0.0354) (4.18) (2.444) (5.2126) (0.7935) 
САН 34 81 89 4.89 72 2493 93 10.24 
(29.16) (0.89) (0.0489) (4.50) (2.493) (5.1987) (0.6236) 
C P H 22 74 108 4.07 58 3573 79.04 9.16 
(26.64) (1.03) (0.0407) (3.62) (3.573) (4.4183) (0.5578) 
L C 64 76 77.62 3.5 65 18.07 77 12.18 
(27.36) (0.776) (0.035) (4.06) (1.807) (4.3043) (0.7418) 
L S 37 84 103 5.1 65 3200 78 10.5 
(30.24) (1.03) (0.051) (4.06) (3.200) (4.3602) (0.6395) 
E C 48 90 1ЗЗ.9 6.75 84 2440 88 9.25 
(32.40) (1:339) (0.0675) (5.25) (2.440) (4.9192) (0.5633) 
Neoplasms 30 99.8 100.16 4.67 74.56 1832 87.43 11.68 
(35.92) (1.0016) (0.0467) (4.66) (18.32) (4.8833) (0.7113) 
Orosomucoid was reduced down to the lower reference limit in A V H (medium 
severe and severe forms) and in L C patients where grave parenchymatous lesions 
were established. Orosomucoid was increased only in patients with E C syndrome 
which was due to inflammatory phenomena. 
Hp level remained normal in all patients' groups. However, its mean level 
was lower in A V H , САН and L C patients when compared with that bf the con­
trols due to inflammatory and destructive alterations and to reduced biosynthes­
is in damaged liver. 
Ceruloplasmin (Cp) was in reference values with all the patients excepting 
HC and E C ones where it was increased. This increase could be due to hyperpro-
duction, persistent cholangitis and hampered bile drainage because of tumours. 
There was serum C E level reduction in L C , HC and severe A V H . Its activity 
changed parallelly to the severity of the pathological process when A V H was 
concerned. C E possessed no diagnostical value in the other patients' groups be­
cause it was within reference values in most cases. 
HA were maximally increased in A V H and САН, moderately — in EC and 
HC while remaining unchanged in rest patients (fig. 2). 
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F was enhanced in A V H and L C but its increase was slightlier in HC pati­
ents (Jig. 3). 
It was, therefore, evident that chronic liver diseases were characterized by 
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Fig . 1. Sialic acid (SA) in the serum of patients studied 
found out that serum immunoglobulins IgG, IgM and IgA were increased in a 
different percentage of patients with chronic liver diseases. In any САН cases 
and L C without ascites patients IgG was enhanced while it was observed in 94 8 
per cent of L C cases with ascites to be elevated. Serum IgG was almost equally 
frequently increased in C P H , HC and E C patients while it was established less 
frequently in L S ones. Serum IgM was increased most often in САН cases (86.4 
per cent) whereas this increase was established no more than in the half of the 
other patients' groups. Serum IgA was increased in 100 per cent of САН patients, 
as well as in E C patients where the cause was extrahepatic duct carcinoma and 
in 87.5 per cent of L C cases. We found out serum IgA increase in patients with 
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chronic liver diseases in similar frequency to that of IgG. There was IgA increase 
in 81.8 per cent of HC patients probably due to the present E C . Serum IgG show­
ed the highest level in САН and L C and less expressed one in HC, C P H , E C , and 




























2. Hexosamines (HA) in the serum of patients studied 
iderably lower but still over the normal range in L C ones. IgM was not changed 
in other patients' groups. 
Serum IgA was increased in САН, HC, L C , and E C patients. Its increase was 
less expressed in CHP and L S cases. 
Our study revealed the most significant abnormalities in САН and L C pa­
tients among the cases with chronic liver diseases which was likely due to immune 
or autoimmune, respectively, mechanisms. Other investigators reported similar 
data in САН patients (2, 5, 10, 15, 18, 20). Dynamic follow-up of immunoglobu­
lins could provide information concerning the dynamics of the disease and the 
Ъ Scripta scientifica medica 
82 R. Pateva, Е. Rusinov 
degree of expressiveness of mesenchymal inflammatory reaction. By this way 
they can be useful in early diagnosis of chronic liver diseases. It is possible 
that immunologic deviations and suppression of certain immune mechanisms 
result in a lower percentage of increased IgM in single patients' groups. 
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Fig. 3. Fucose (F) in the serum of patients studied 
We can draw the following conclusions: 
1. Abnormalities of serum glycoproteins and immunoglobulins argue mainly 
for the activity of the pathological process and the degree of liver damage. j 
2. Glycoproteins possess the highest information value when changed in 
patients with A V H , L C , E C , and HC but immunoglobulins — in САН, CPH, L S , 
L C , E C , and HC cases. 
3. The investigation of ISP helps the differential diagnosis of different chron­
ic liver diseases which is important to determine the evolution and therapy 
of the illness. 
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К ИЗМЕНЕНИЯ ИНДИВИДУАЛЬНЫХ СЫВОРОТОЧНЫХ БЕЛКОВ 
ПРИ ЗАБОЛЕВАНИЯХ ПЕЧЕНИ 
Р . Пашева, Е. Русинов 
Р Е З Ю М Е * 
Исследовано 360 больных заболеваниями печени в профилированной гастроэнтероло­
гической клинике и в инфекционной клинике. Средний возраст больных — 53 года. Обо­
соблены группы больных острым вирусным гепатитом, хроническим активным гепатитом, 
хроническим персистирующим гепатитом, циррозом печени, стеатозом печени, раком пе­
чени и экстрагепатальным холеостазом. Была исследована также группа контрольных лиц . 
Д л я определения индивидуальных сывороточных белков использовались специфические 
химические реакции, а для определения иммуноглобулинов — иммунохимические. Откло­
нения от нормы иммуноглобулинов и гликопротеинов говорят об активности процесса бо­
лезни и о степени увреждения печени. Наибольшую диагностическую информативность 
содержат изменения гликопротеинов у больных острым вирусным гепатитом, циррозом пе-
чени, экстрагепатальным холестазом и раком печени, а изменения иммуноглобулинов — 
|.у больных хроническим активным гепатитом, хроническим персистирующим гепатитом, 
стеатозом печени, циррозом печени, экстрагепатальным холестазом и раком печени. Иссле­
д о в а н и е гликопротеинов и иммуноглобулинов способствует проведению дифференциаль­
н о г о диагноза различных хронических заболеваний, что имеет важное значение для о п р е ­
деления эволюции и терапии заболевания. 
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